Adtalem Global Education (NYSE:CVSA) CAO Manjunath Gangadharan Sells 1,802 Shares

Adtalem Global Education Inc. (NYSE:CVSA) CAO Manjunath Gangadharan sold 1,802 shares of Adtalem Global Education stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $137.18, for a total value of $247,198.36. Following the sale, the chief accounting officer owned 5,083 shares in the company, valued at $697,285.94. This trade represents a 26.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

Adtalem Global Education stock opened at $134.71 on Friday. The stock has a market cap of $4.59 billion, a P/E ratio of 19.13, a P/E/G ratio of 1.04 and a beta of 0.62. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The firm has a 50-day moving average price of $127.39.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. The firm had revenue of $501.38 million for the quarter. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, analysts forecast that Adtalem Global Education Inc. will post 9 earnings per share for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new stake in Adtalem Global Education Inc. (NYSE:CVSA) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CVSA has been the topic of a number of recent research reports. Truist Financial lifted their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a report on Monday, May 11th. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Barrington Research reissued an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research report on Monday, June 8th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Wednesday, August 19th. Two equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.